If at any time while reading this article your attention wanders, you may have ADHD. If you pause to check your email sometime during the next three paragraphs, you should consult a doctor. If you fail to read this article all the way to the end, you should get on Adderall, Ritalin or some other drug to treat your condition as soon as possible.
This isn’t quite the standard for diagnosing attention-deficit hyperactivity disorder, but it’s close. The New York Times ran a long expose on how the drug industry has stoked the diagnosis and treatment of ADHD that had a revelatory quote from Keith Conners, a doctor who has long advocated for the recognition of the disorder.
Conners called the overdiagnosis of ADHD “a national disaster of dangerous proportions,” telling the Times that the rising number of cases “is a concoction to justify the giving out of medication at unprecedented and unjustifiable levels.” This isn’t bomb-throwing from an outsider, but a critique from the namesake of the Conners ratings scale widely used to evaluate kids for ADHD.
There is no doubt that ADHD is a legitimate neurological condition that makes kids (and those around them) miserable, that blights their potential and that can be alleviated by prescription stimulants like Adderall and Ritalin. There also is no doubt that diagnosis and treatment of the disorder has run wildly out of control. According to the forthcoming book “The ADHD Explosion,” 19 percent of high-school-aged males have received a diagnosis. The numbers differ from state to state. In North Carolina, an astounding 30 percent of boys over age 9 are supposedly suffering from ADHD. Overall, 6 percent of children and adolescents in the United States are on drugs to treat ADHD.
It’s a wonder more kids aren’t diagnosed with it, given the overlap between the description of the disorder and failings to which we are all prone. The New York Times points out that the American Psychiatric Association criteria for ADHD include “often has difficulty waiting his or her turn” and “makes careless mistakes,” hardly rare childhood behaviors.
The drug companies — for whom ADHD is a $9 billion-a-year business — target mothers with alluring ads suggesting their children will become little angels through the wonders of risk-free stimulants. Their kids will get better grades, spend more quality time with the family and remember to take out the trash. Who wouldn’t want their child thus magically transformed? According to the Times report, the Food and Drug Administration has constantly rebuked the companies for going beyond the evidence in selling visions of childhood Valhalla secured through the right drug.
Undertrained primary-care physicians and worried parents default much too often to the diagnosis of ADHD and to the answer of a prescription. The next frontier is adult ADHD, with the promise of a vast new pharmaceutical market made up of people deprived of ADHD diagnoses when they were children. Some of these diagnoses will be warranted and life-changing, but others will be overreach prompted by vague and dubious symptoms, like inattentive op-ed reading.
Sure, you got to the end of this article. But how about the next one?
Rich Lowry is editor of the National Review.